非洲生物分析测试服务市场 – 行业趋势和 2029 年预测

市场分析和见解

对生物制剂和生物仿制药分析测试的日益关注增强了市场的需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期，主要市场参与者专注于各种服务的推出和批准。此外，对外包分析测试的日益偏好也促进了该地区对生物分析测试服务的需求不断增长。

由于市场参与者的增加和先进服务的可用性，预测年非洲生物分析测试服务市场将增长。与此同时，制造商正致力于研发活动，以在市场上推出新服务。对专业生物分析测试服务的需求不断增长，进一步推动了市场增长。然而，预测期内，熟练专业人员的短缺和主要参与者面临的定价压力可能会阻碍非洲生物分析测试服务市场的发展。

医疗保健支出的增加和市场参与者的战略举措为市场提供了提升的机会。然而，创新配方需要独特的生物分析测试方法，而提高生物分析方法灵敏度的需求日益增加，这是市场增长的关键挑战。

Data Bridge Market Research 显示，2022 年至 2029 年期间非洲生物分析测试服务市场将以 6.8% 的复合年增长率增长。

市场定义

Bioanalytical testing is the quantitative determination of drugs and/or metabolites in biological matrices such as blood, serum, plasma, or urine, tissue, and skin samples specifically applied to toxicology, pharmacology, bioequivalence, pharmacokinetics, and bioavailability studies in animals or humans. Bioanalytical services are provided to researchers by contract research organizations with the resources, expertise, instrumentation, and technology to tackle the most complex programs across multiple modalities and therapeutic areas for clinical and preclinical bioanalysis.

Bioanalytical Testing Services Market Dynamics

Drivers

• Rise in focus on the analytical testing of biologics and biosimilar

Biologics represent one of the most promising new therapeutic areas and are becoming increasingly important in the pharmaceutical market; around 800 products are in the pipeline. One of the key reasons for this is the rising prevalence of chronic diseases.

According to the Biomed Central article in May 2020, it is reported that Africa faces a double burden of infectious and chronic diseases. Age-specific mortality rates from chronic diseases are higher in sub-Saharan Africa than in virtually all other regions, both men and women. Over the next ten years, the continent is projected to experience the most significant increase in death rates from cardiovascular disease, cancer, respiratory disease, and diabetes

The expected rise in biosimilar R&D will bring a growing demand for the associated bioanalytical testing services—compatibility studies for biosimilar, stability testing, product release testing, and protein analysis of biosimilar—to reduce the risks associated with drug development. Moreover, the introduction of biosimilar and the move toward continuous processing create the need for more rapid and sensitive analytical techniques.

• Increase in preference for outsourcing analytical testing

The outsourcing of bioanalytical testing services supports pharmaceutical companies lessen risks by avoiding significant funds in purchasing analytical equipment and maintaining the workforce, mainly when development efforts are in the initial stages. The accessibility of specialized analytical testing service providers with critical capabilities to deliver optimal results rapidly has led to growing consideration among pharmaceutical businesses to outsource testing services to third-party service providers.

Hence, the Increasing preference for outsourcing analytical testing is expected to drive the market in the forecasted period.

Opportunity

• Rising adoption of the quality by design approach

A rising number of conferences, symposia, workshops, and training courses, especially in emerging countries, have played a crucial role in creating awareness about the benefits of adopting the QbD approach among pharmaceutical and biopharmaceutical manufacturers and research organizations.

The increasing acceptance and adoption of the QbD approach among pharmaceutical and biopharmaceutical companies across the region are expected to play a key role in the growth of the bioanalytical testing services market in the coming years.

Restraint/Challenge

• Dearth of skilled professionals

The shortage of skilled professionals to handle advanced equipment required for bioanalytical tests is a significant factor that is expected to restrain the growth of this market. In the African countries as there is less awareness among people to work in such industry and acquire specific skills related to this field

For instance,

As per the World Economic Forum article in September 2019, it is observed that the current lack of skills has real consequences. Of the CEOs highly concerned about the availability of key skills, 65% of African CEOs said the skills shortage prevented them from innovating effectively. In comparison, 59% conceded that their quality standards and customer experience were being undermined. In addition, 54% confirmed that they were missing their growth targets because of inadequate skills

This may hamper the adoption of new technologies and methodologies, thereby limiting the growth of the bioanalytical testing services market in the coming years.

Post-COVID-19 Impact on Africa Bioanalytical Testing Services Market

COVID-19 has negatively affected the market. Lockdowns and isolations during pandemics complicate clinical trials. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

• In January 2022, SGS SA announced that the company had collaborated Microsoft. The collaboration has integrated Microsoft's cross-industry expertise, advanced data solutions and productivity platforms, and the global network and leading industry competence to develop innovative solutions for the Testing, Inspection and Certification (TIC) industry's customers. This will help the company to increase its global presence and make strong foot-prints in the market

Africa Bioanalytical Testing Services Market Scope

Africa bioanalytical testing services market is categorized into two notable segments, such as type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Bioanalytical Services For Preclinical And Clinical Studies
• Small Molecule Bioanalytical Services
• Large Molecule Bioanalytical Services

Based on type, the Africa bioanalytical testing services market is segmented into bioanalytical services for preclinical and clinical studies, small molecule bioanalytical services and large molecule bioanalytical services.

End User

• Clinical Research Organization
• Pharmaceutical And Biotechnology Companies
• Hospitals Labs
• 学术及研究机构
• 其他的

根据最终用户，非洲生物分析测试服务市场分为临床研究组织、制药和生物技术公司、医院实验室、学术和研究机构等。

生物分析测试服务市场区域分析/见解

对生物分析测试服务市场进行了分析，并按类型和最终用户提供了市场规模洞察和趋势，如上所述。

生物分析测试服务市场报告涉及的国家包括南非、尼日利亚、安哥拉、埃塞俄比亚和非洲其他国家。

由于制药和生物制药行业研发支出不断增长，非洲生物分析测试服务市场预计将增长。此外，该地区对外包分析测试的偏好增加将进一步推动预测期内的市场增长。

预计南非将在市场份额和市场收入方面主导非洲生物分析测试服务市场。在预测期内，它将继续保持主导地位。这是由于对生物分析服务的需求很高。

报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新车和替换车销售、国家人口统计数据和进出口关税等数据点是预测单个国家市场情况的一些重要指标。此外，在对国家数据进行预测分析时，还考虑了非洲品牌的存在和可用性、它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。

竞争格局和生物分析测试服务市场份额分析

生物分析测试服务市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对生物分析测试服务市场的关注有关。

非洲生物分析测试服务市场的一些主要参与者包括 FARMOVS (PTY) LTD、SGS SA、Labcorp、Synexa Life Sciences BV、Q2 Solutions.、Medpace、BARC SOUTH AFRICA、Merieux NutriSciences Corporation 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、非洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68811